Download full announcement NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the issuer or... read more →
Download full announcement RenalytixAI machine learning approach outperformed current standard of care in 1,369 patient study Renalytix AI plc(AIM: RENX), the developer of artificial intelligence-enabled diagnostics for kidney disease, announces... read more →
Download full announcement Renalytix AI plc (AIM: RENX), the AIM quoted developer of artificial intelligence-enabled diagnostics for kidney disease, announces its inaugural unaudited interim results for the six months ended... read more →
Download full announcement Investigators include leading transplant clinicians from Emory University, the University of Manitoba, the Westmead Hospital Sydney, and Icahn School of Medicine at Mount Sinai. Renalytix AI plc(LON:... read more →
Download full announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled diagnostics for kidney disease, announces that it will host investor briefings focused on AI-enabled diagnostics and kidney... read more →
Download full announcement Further to the announcement on 20 December 2018, Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled diagnostics for kidney disease, announces the appointment of Stifel... read more →
Download full announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled diagnostics for kidney disease, announces the completion of a joint venture partnership agreement with AKESOgen, an industry-leading commercial laboratory facility... read more →
Company Adds Clinical and Data Security Expertise to Support KidneyIntelX Clinical Validation, Software and Regulatory Programmes Download full announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled diagnostics... read more →
Validation study to assess approximately 5,000 patients with participation from a multi-center group of leading U.S. investigators Download full announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled... read more →
Download full announcement This announcement relates solely to ordinary shares in the Company which were distributed to certain qualifying shareholders owning EKF Diagnostic Holdings plc shares prior to admission (the... read more →